3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012
11/12/2012 10:15:53 AM
More...
|
3-V Biosciences to Present Data on HCV Product Candidates at the American Association for Study of Liver Diseases Annual Meeting 2012
10/1/2012 11:09:11 AM
More...
|
3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
7/10/2012 9:50:37 AM
More...
|
3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
6/29/2012 10:39:00 AM
More...
|
3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer
8/15/2011 11:31:16 AM
More...
|
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
2/10/2011 7:24:03 AM
More...
|
3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer
9/30/2010 8:03:09 AM
More...
|
James F. Young Joins 3-V Biosciences Board of Directors
7/21/2010 9:58:54 AM
More...
|
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
6/3/2010 9:02:39 AM
More...
|
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
5/13/2010 7:11:43 AM
More...
|
|